Cambrex Corp., a manufacturer of small molecule innovator and generic APIs, has completed an expansion of its large-scale production capacity at its Charles City, IA plant. The investment included the installation of 1,000 and 4,000 gallon glass lined reactors and additional equipment.   The new reactors have been installed in the 7,500 sq.-ft., multi-purpose, manufacturing facility, bringing the cGMP reactor capacity to 23,000 gallons, and the total capacity at the Charles City facility to ap...